We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01660542
Recruitment Status : Completed
First Posted : August 8, 2012
Last Update Posted : November 1, 2016
Information provided by (Responsible Party):
Yonsei University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2015
  Study Completion Date : June 2015